Baxter International, Inc. (BAX)'s PREFLUCEL Seasonal Influenza Vaccine Receives European Repeat Mutual Recognition Approval  
3/2/2011 9:16:55 AM

VIENNA, Austria--(BUSINESS WIRE)--Baxter International Inc. announced today the approval of a European repeat mutual recognition procedure (rMRP) by the Austrian Agency for Health and Food Safety for Baxter’s PREFLUCEL seasonal influenza vaccine. The 13 participating European Union countries, including Germany, Spain, United Kingdom and Nordic countries, will formally implement the license on a national level to make PREFLUCEL available for the 2011-12 influenza season.